The University of Adelaide's world-class researchers continuously create cutting-edge technologies that benefit society.
We are actively seeking commercial partners for a number of our existing technologies and research projects from right across the University's research footprint - including communications, medical, advanced manufacturing and sustainable technologies. For a snapshot of these, browse our portfolio.
A simple and intensive DNA vaccine that elicits robust humoral and cell mediated immune response to the Zika virus NS1 protein, resulting in protection against challenge.
DNA vaccines show exciting translational prospects for development of effective vaccines to prevent establishment of persistent infection.
Our Hybrid Receiver Combustor offers efficient, cost-effective, modular cavity receivers that integrate solar thermal and gas combustion. Potential benefits include lower cost of solar thermal power due to reduced infrastructure, firm supply, and potential thermodynamic synergies.
A solar-induced system for photocatalytic conversion of water into fuels such as hydrogen and methane.
Real time cancer cell detector for clean margins in primary breast cancer surgery.
Targeting chronic rhinosinusitis, researchers at the University of Adelaide have identified an effective way of treating biofilms by targeting essential iron metabolism pathways in pathological bacteria.
Working with a research compound to inhibit a specific Carbonic Anhydrase (CA), our team is targeting the Osteocyte, rather than the Osteoclast, hypothesising that this mechanism of action should result in lower side effects, and reduced risk of rebound post treatment.